The Department of Justice (DOJ) has encountered a significant hurdle in its Medicare Advantage fraud case against Elevance Health, as the company blocks access to a key witness. Government attorneys revealed this week that Elevance is preventing the deposition of Peter Haytaian, an outgoing executive who previously led the insurer’s Medicare Advantage operations.

The dispute centers on a letter sent by DOJ attorneys to a federal judge, detailing how Elevance announced Haytaian’s departure shortly after the DOJ first requested his testimony. This timing, the DOJ argues, may be an attempt to obstruct access to a critical witness in the case.

The legal battle, initiated by the DOJ in 2020, highlights the escalating scrutiny surrounding Elevance’s Medicare Advantage plans. These plans, designed for seniors, generated over $40 billion in revenue last year alone, underscoring the financial stakes involved.

Source: STAT News